Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

MicroRNA-122 Mediated Protection of the Hepatitis C Virus Genome from Human Pyrophosphatases

FY 2019-20

Summary
"Hepatitis C virus (HCV) infects approximately 71 million people worldwide, including 268,000 Canadians. HCV is an RNA virus that directly interacts with a highly abundant, liver-specific human small RNA, termed miR-122. HCV binds to two miR-122 molecules, which facilitates HCV infection. Treatment of patients with chronic HCV using a miR-122 inhibitor led to significant reductions in viral loads. However, in some patients, upon treatment cessation, HCV levels rebounded and several resistance-associated variants were identified. Until recently, the mechanism(s) of how miR-122 is able to promote HCV RNA accumulation were unclear; however, recent studies from our group have demonstrated that miR-122 protects the HCV genome from recognition by host cell enzymes that would typically degrade the viral RNA. Specifically, miR-122 protects the viral genome from recognition by two cellular pyrophosphatases which can initiate the decay pathway. However, the precise requirements for the activity of these enzymes is not known. Thus, we plan to study these cellular enzymes and determine their substrate requirements and also investigate how the resistance-associated variants of HCV identified in patients are able to prevent recognition by these enzymes, even in the absence of miR-122."
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428858
Name
Hayes Rachel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
MicroRNA-122 Mediated Protection of the Hepatitis C Virus Genome from Human Pyrophosphatases
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
5-Triphosphate; Hepatitis C Virus; Host-Virus Interaction; In Vitro; Microrna-122; Protein-Rna Interaction; Pyrophosphatase
Abstract
"Hepatitis C virus (HCV) infects approximately 71 million people worldwide, including 268,000 Canadians. HCV is an RNA virus that directly interacts with a highly abundant, liver-specific human small RNA, termed miR-122. HCV binds to two miR-122 molecules, which facilitates HCV infection. Treatment of patients with chronic HCV using a miR-122 inhibitor led to significant reductions in viral loads. However, in some patients, upon treatment cessation, HCV levels rebounded and several resistance-associated variants were identified. Until recently, the mechanism(s) of how miR-122 is able to promote HCV RNA accumulation were unclear; however, recent studies from our group have demonstrated that miR-122 protects the HCV genome from recognition by host cell enzymes that would typically degrade the viral RNA. Specifically, miR-122 protects the viral genome from recognition by two cellular pyrophosphatases which can initiate the decay pathway. However, the precise requirements for the activity of these enzymes is not known. Thus, we plan to study these cellular enzymes and determine their substrate requirements and also investigate how the resistance-associated variants of HCV identified in patients are able to prevent recognition by these enzymes, even in the absence of miR-122."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hayes, Rachel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~